29330 Federal Register / Vol. 72, No. 101 / Friday, May 25, 2007 / Notices 

Federal Protective Service or Guard 

Service personnel before entering the 

building. 

• Security measures include 

inspection of vehicles, inside and out, at 

the entrance to the grounds. 

• In addition, all persons entering the 

building must pass through a metal 

detector. 

• All items brought into CMS—

including personal items such as 

desktops, cell phones, palm pilots, 

etc.—are subject to physical inspection. 

• The public may enter the building 

30–45 minutes before the meeting 

convenes each day. 

• All visitors must be escorted in 

areas other than the lower and first-floor 

levels in the Central Building. 

• The main-entrance guards will 

issue parking permits and instructions 

upon arrival at the building. 

IX. Special Accommodations 

Individuals requiring sign-language 

interpretation or other special 

accommodations must send a request 

for these services to the DFO by 5 p.m. 

(e.s.t.), Wednesday, August 29, 2007. 

Authority: Section 1833(t)(9) of the Act (42 

U.S.C. 13951(t)). The Panel is governed by 

the provisions of Pub. L. 92–463, as amended 

(5 U.S.C. Appendix 2). 

(Catalog of Federal Domestic Assistance 

Program No. 93.773, Medicare-Hospital 

Insurance; and Program No. 93.774, 

Medicare-Supplementary Medical Insurance 

Program) 

Dated: May 1, 2007. 

Leslie V. Norwalk, 

Acting Administrator, Centers for Medicare 

& Medicaid Services. 

[FR Doc. E7–9521 Filed 5–24–07; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–1546–N] 

Medicare Program; Public Meeting in 

Calendar Year 2007 for New Clinical 

Laboratory Tests Payment 

Determinations 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice. 

SUMMARY: This notice announces a 

public meeting to discuss payment 

determinations for specific new 

Physicians’ Current Procedural 

Terminology (CPT) codes for clinical 

laboratory tests. The meeting provides a 

forum for interested parties to make oral 

presentations and submit written 

comments on the new codes that will be 

included in Medicare’s Clinical 

Laboratory Fee Schedule for calendar 

year 2008, which will be effective on 

January 1, 2008. The meeting will 

address technical issues relating to 

payment determinations for a specified 

list of new clinical laboratory codes. 

The development of the codes for 

clinical laboratory tests is performed by 

the CPT Editorial Panel and will not be 

discussed at the CMS meeting. 

DATES: The public meeting is scheduled 

for Monday, July 16, 2007 from 10 a.m. 

to 2 p.m. 

ADDRESSES: The public meeting will be 

held in the main auditorium of the 

central building of the Centers for 

Medicare & Medicaid Services (CMS) 

located at 7500 Security Boulevard, 

Baltimore, Maryland 21244. 

FOR FURTHER INFORMATION CONTACT: 

Anita Greenberg, (410) 786–4601. 

SUPPLEMENTARY INFORMATION: 

I. Background 

Section 531(b) of the Medicare, 

Medicaid, and SCHIP Benefits 

Improvement and Protection Act of 

2000 (BIPA), Pub. L. 106–554, mandated 

procedures that permit public 

consultation for payment 

determinations for new clinical 

laboratory tests under Part B of title 

XVIII of the Social Security Act (the 

Act) in a manner consistent with the 

procedures established for 

implementing coding modifications for 

International Classification of Diseases 

(ICD–9–CM). The procedures and public 

meeting announced in this notice for 

new clinical laboratory tests are in 

accordance with the procedures 

published on November 23, 2001 in the 

Federal Register (66 FR 58743) to 

implement section 531(b) of BIPA. Also, 

section 942(b) of the Medicare 

Prescription Drug, Improvement, and 

Modernization Act of 2003 (MMA), Pub. 

L. 108–173, added section 

1833(h)(8)(B)(iii) of the Act, which 

required that we establish by regulation 

procedures for determining the basis for, 

and amount of, payment for new 

clinical laboratory tests. In the calendar 

year (CY) 2007 physician fee schedule 

final rule (71 FR 69701 through 69704), 

we adopted new 42 CFR subpart G 

regarding payment for new clinical 

diagnostic laboratory tests. Under 42 

CFR 414.506, we annually convene a 

meeting that includes representatives of 

CMS officials involved in determining 

payment amounts to receive individual 

comments and recommendations (and 

data on which the recommendations are 

based). 

A newly created CPT code can either 

represent a refinement or modification 

of existing test methods, or a 

substantially new test method. The 

newly created CPT codes for the 

calendar year 2007 will be listed at the 

web site http://www.cms.hhs.gov/ 

ClinicalLabFeeSched on or after June 18, 

2007. 

The first method, called crosswalking, is used when a new test is 

determined to be similar to an existing 

test, multiple existing test codes, or a 

portion of an existing test code. The 

new test code is then assigned the 

related existing local fee schedule 

amounts and resulting national 

limitation amount. The second method, 

called gap-filling, is used when no 

comparable, existing test is available. 

When using this method, instructions 

are provided to each Medicare carrier to 

determine a payment amount for its 

geographic area(s) for use in the first 

year, and the carrier-specific amounts 

are used to establish a national 

limitation amount for following years. 

For each new clinical laboratory test 

code, a determination must be made to 

either cross-walk or to gap-fill, and, if 

cross-walking is appropriate, to know 

which tests to cross-walk. 

II. Meeting Format 

This meeting is open to the public. 

The on-site check-in for visitors will be 

held from 9:30 to 10 a.m., followed by 

opening remarks. Registered individuals 

may discuss and recommend payment 

determinations for specific new CPT 

codes for the 2008 Clinical Laboratory 

Fee Schedule. 

Oral presentations must be brief, and 

must be accompanied by three written 

copies. Presenters may also make copies 

available for approximately 50 meeting 

participants. Presenters should address 

the new test code(s) and descriptor, the 

test purpose and method, costs, charges, 

and make a recommendation with 

rationale for using one of two methods 

(cross-walking or gap-fill) for 

determining payment for new clinical 

laboratory codes. Presentations that do 

not address the six items may be 

considered incomplete and not 

considered by CMS when making a 

payment determination. We will request 

missing information following the 

meeting in order to prevent a 

recommendation from being considered 

incomplete. 

A summary of the new codes and the 

payment recommendations that are 

presented during the public meeting 

will be posted on our Web site by 

September 7, 2007 and can be accessed 

at http://www.cms.hhs.gov/ 

ClinicalLabFeeSched. In addition, the 


jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 72, No. 101 / Friday, May 25, 2007 / Notices 29331 

summary will list other comments 

received on or before 15 days after the 

meeting, or August 1, 2007. The 

summary will also display CMS’

tentative payment determinations, and 

interested individuals may submit 

written comments on the tentative 

payment determinations by September 

21, 2007 to the address specified in the 

summary. 

III. Registration Instructions 

We are coordinating the public 

meeting registration. Beginning June 18, 

2007 registration may be completed online at http://www.cms.hhs.gov/ 

ClinicalLabFeeSched. The following 

information must be submitted when 

registering: Name; company name; 

address; telephone number(s); and Email address(es). 

When registering, individuals who 

want to make a presentation must also 

specify which new clinical laboratory 

test code(s) they will be presenting. A 

confirmation will be sent upon receipt 

of the registration. 

Registration Deadline: Individuals 

must register by July 11, 2007. 

IV. Security, Building, and Parking 

Guidelines 

The meeting will be held in a Federal 

government building; therefore, Federal 

security measures are applicable. In 

planning your arrival time, we 

recommend allowing additional time to 

clear security. In order to gain access to 

the building and grounds, participants 

must bring a government-issued photo 

identification and a copy of your written 

meeting registration confirmation. 

Persons without proper identification 

may be denied access to the building. 

Individuals who are not registered in 

advance will not be permitted to enter 

the building and will be unable to 

attend the meeting. The public may not 

enter the building earlier than 30 to 45 

minutes prior to the convening of the 

meeting. 

Security measures also include 

inspection of vehicles, inside and out at 

the entrance to the grounds. In addition, 

all persons entering the building must 

pass through a metal detector. All items 

brought to CMS, whether personal or for 

the purpose of demonstration or to 

support a presentation, are subject to 

inspection. 

V. Special Accommodations 

Individuals attending a meeting who 

are hearing or visually impaired and 

have special requirements, or a 

condition that requires special 

assistance, should provide the 

information upon registering for the 

meeting. 

Authority: Section 1102, 1833(h), and 1871 

of the Social Security Act (42 U.S.C. 1302, 42 

U.S.C. 13951, and 42 U.S.C. 1395hh) 

(Catalog of Federal Domestic Assistance 

Program No. 93.774, Medicare—

Supplementary Medical Insurance Program) 

Dated: March 22, 2007. 

Leslie V. Norwalk, 

Acting Administrator, Centers for Medicare 

& Medicaid Services. 

[FR Doc. E7–9525 Filed 5–24–07; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–3172–N] 

Medicare Program; Meeting of the 

Medicare Coverage Advisory 

Committee—July 18, 2007 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice. 

SUMMARY: This notice announces a 

public meeting of the Medicare 

Evidence Development Coverage 

Advisory Committee (MedCAC or 

Committee), formerly the Medicare 

Coverage Advisory Committee (MCAC). 

The Committee generally provides 

advice and recommendations about 

whether scientific evidence is adequate 

to determine whether certain medical 

items and services are reasonable and 

necessary under the Medicare statute. 

This meeting concerns percutaneous 

transluminal angioplasty (PTA) and 

stenting of the renal arteries. 

Notice of this meeting is given under 

the Federal Advisory Committee Act (5 

U.S.C. App. 2, section 10(a)). 

DATES: Meeting Date: The public 

meeting will be held on Wednesday, 

July 18, 2007 from 7:30 a.m. until 4:30 

p.m., eastern daylight time (e.d.t.). 

Deadlines for Registration and 

Request for Special Accommodations: 

Registration must be completed no later 

than 5 p.m., e.d.t. on Monday, July 9, 

2007. Request for special 

accommodations must be received by 5 

p.m., e.d.t. Tuesday, July 10, 2007. 

Deadlines for Written Comments and 

Presentations: Written comments and 

presentations must be received by June 

18, 2007, 5 p.m., e.d.t. Presentations, 

once submitted, are final. No further 

changes to the presentation can be 

accepted after submission. 

ADDRESSES: Meeting Location: The 

meeting will be held in the main 

auditorium of the Centers for Medicare 

& Medicaid Services, 7500 Security 

Boulevard, Baltimore, MD 21244. 

Presentation and Comment 

Submission: Interested persons may 

present data, information, or views 

orally or in writing on issues pending 

before the Committee. Presentation and 

written comments must be submitted by 

e-mail to 

Michelle.Atkinson@cms.hhs.gov or by 

regular mail to Michelle Atkinson, 

Executive Secretary for MedCAC, 

Centers for Medicare & Medicaid 

Services, Office of Clinical Standards 

and Quality, Coverage and Analysis 

Group, C1–09–06, 7500 Security 

Boulevard, Baltimore, MD 21244. 

Registration and Special 

Accommodations: Individuals wishing 

to participate or who need special 

accommodations, or both, may register 

by phone or e-mail by contacting Maria 

Ellis at 410–786–0309 or 

Maria.Ellis@cms.hhs.gov no later than 5 

p.m., e.d.t on Monday, July 9, 2007. 

Persons attending the meeting who are 

hearing or visually impaired, or have a 

condition that requires special 

assistance or accommodations, are 

asked to contact Michelle Atkinson, 

Executive Secretary for MedCAC, no 

later than July 9, 2007. 

Web site: You may access up-to-date 

information on this meeting at http:// 

www.cms.hhs.gov/FACA/ 

02_MCAC.asp#TopOfPage. 

FOR FURTHER INFORMATION CONTACT: 

Michelle Atkinson, Executive Secretary 

for MedCAC, 410–786–2881; 

Michelle.Atkinson@cms.hhs.gov; 

Centers for Medicare & Medicaid 

Services, OCSQ—Coverage and Analysis 

Group, C1–09–06, 7500 Security 

Boulevard, Baltimore, MD 21244). 

SUPPLEMENTARY INFORMATION: 

I. Background 

On December 14, 1998, we published 

a notice in the Federal Register (63 FR 

68780) to describe the Medicare 

Coverage Advisory Committee (MCAC), 

which provides advice and 

recommendations to CMS about clinical 

issues. 

This notice announces the July 18, 

2007 public meeting of the Committee. 

During this meeting, the Committee will 

discuss evidence and hear presentations 

from the public concerning the use of 

PTA and stenting of the renal arteries 

for the treatment of atherosclerotic renal 

artery stenosis (ARAS). The clinical 

outcomes in the Medicare population 

will be discussed. MedCAC will review 

the following kinds of evidence: 

• The most informative measures of 

clinical outcomes. 

• Indications. 


jlentini on PROD1PC65 with NOTICES